Banks WA, Jaspan JB, Kastin AJ. Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays. Peptides 1997; 18(8): 1257–62
PubMed
CAS
Article
Google Scholar
Banks WA, Jaspan JB, Huang W, et al. Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides 1997; 18(9): 1423–9
PubMed
CAS
Article
Google Scholar
Baskin D, Figlewicz D, Woods S, et al. Insulin in the brain. Annu Rev Physiol 1987; 49: 335–47
PubMed
CAS
Article
Google Scholar
Baura GD, Foster DM, Porte Jr D, et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo: a mechanism for regulated insulin delivery to the brain. J Clin Invest 1993; 92(4): 1824–30
PubMed
CAS
Article
Google Scholar
Wallum BJ, Taborsky GJ, Porte D, et al. Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. J Clin Endocrinol Metab 1987; 64(1): 190–4
PubMed
CAS
Article
Google Scholar
Havrankova J, Roth J. Insulin receptors are widely distributed in the central nervous system of the rat. Nature 1978; 272: 827–9
PubMed
CAS
Article
Google Scholar
Havrankova J, Schmechel D, Roth J, et al. Identification of insulin in rat brain. Proc Natl Acad Sci U S A 1978; 75(11): 5737–41
PubMed
CAS
Article
Google Scholar
Unger J, Livingston J, Moss A. Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. Prog Neurobiol 1991; 36: 343–62
PubMed
CAS
Article
Google Scholar
Reagan L, Gorovits N, Hoskin E, et al. Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats. Proc Natl Acad Sci U S A 2001; 98(5): 2820–5
PubMed
CAS
Article
Google Scholar
Apelt J, Mehlhorn G, Schliebs R. Insulin-sensitive GLUT4 glucose transporters are colocalized with GLUT3-expressing cells and demonstrate a chemically distinct neuron-specific localization in the brain. J Neurosci Res 1999; 57: 693–705
PubMed
CAS
Article
Google Scholar
Brant A, Jess T, Milligan G, et al. Immunological analysis of glucose transporters expressed in different regions of the rat brain and central nervous system. Biochem Biophys Res Commun 1993; 192(3): 1297–302
PubMed
CAS
Article
Google Scholar
El-Messari S, Leloup C, Quignon M, et al. Immunocytochemical localization of the insulin-responsive glucose transporter 4 (Glut4) in the rat central nervous system. J Comp Neurol 1998; 399(4): 492–512
PubMed
CAS
Article
Google Scholar
Livingstone C, Lyall H, Gould G. Hypothalamic GLUT 4 expression: a glucose- and insulin-sensing mechanism? Mol Cell Endocrinol 1995; 107(1): 67–70
PubMed
CAS
Article
Google Scholar
Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997 Jul–Aug; 18(4): 351–7
PubMed
CAS
Article
Google Scholar
Gasparini L, Gouras GK, Wang R, et al. Stimulation of β-amyloid precursor protein trafficking by insulin reduces intraneuronal β-amyloid and required mitogen-activated protein kinase signaling. J Neurosci 2001; 21(8): 2561–70
PubMed
CAS
Google Scholar
Davis SN, Granner DK. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Hardman JG, Gilman AG, Limbird LE, editors. Gilman and Goodman’s the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996: 1487–1517
Google Scholar
Shii K, Roth RA. Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease. Proc Natl Acad Sci U S A 1986; 83(12): 4147–51
PubMed
CAS
Article
Google Scholar
Joost HG, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members. Mol Membr Biol 2001; 18(4): 247–56
PubMed
CAS
Article
Google Scholar
Schulingkamp R, Pagano T, Hung D, et al. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev 2000; 24: 855–72
PubMed
CAS
Article
Google Scholar
Ibberson M, Uldry M, Thorens B. GLUTX1, a novel mammalian glucose transporter expressed in the central nervous system and insulin-sensitive tissues. J Biol Chem 2000; 275(7): 4607–12
PubMed
CAS
Article
Google Scholar
Kahn BB. Lilly lecture 1995. Glucose transport: pivotal step in insulin action. Diabetes 1996; 45(11): 1644–54
PubMed
CAS
Article
Google Scholar
Rea S, James DE. Moving GLUT4: the biogenesis and trafficking of GLUT4 storage vesicles. Diabetes 1997; 46(11): 1667–77
PubMed
CAS
Article
Google Scholar
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2002; 25Suppl. 1: S5–20
Google Scholar
Reaven G. Insulin resistance in noninsulin-dependent diabetes mellitus: does it exist and can it be measured? Am J Med 1983; 74(1A): 3–17
PubMed
CAS
Article
Google Scholar
Ramlo-Halsted B, Edelman S. The natural history of type 2 diabetes: implications for clinical practice. Prim Care 1999; 26(4): 771–89
PubMed
CAS
Article
Google Scholar
Leyva F, Godsland I, Worthington M, et al. Factors of the metabolic syndrome: baseline interrelationships in the first follow-up cohort of the HDDRISC Study (HDDRISC-1). Arterioscler Thromb Vasc Biol 1998; 18: 208–14
PubMed
CAS
Article
Google Scholar
Meigs J, Mittleman M, Nathan D, et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring study. JAMA 2000; 283(2): 221–8
PubMed
CAS
Article
Google Scholar
Boyko E, de Courten M, Zimmet P, et al. Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance. Diabetes Care 2000; 23: 1242–8
PubMed
CAS
Article
Google Scholar
Craft S, Asthana S, Newcomer JW, et al. Enhancement of memory in Alzheimer’s disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatry 1999; 56: 1135–40
PubMed
CAS
Article
Google Scholar
Fruehwald-Shultes B, Kern W, Bong W, et al. Supraphysiological hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal secretory activity in humans. J Clin Endocrinol Metab 1999; 84: 3041–6
Article
Google Scholar
Tappy L, Randin D, Vollenweider P, et al. Mechanisms of dexamethasone-induced insulin resistance in healthy humans. J Clin Endocrinol Metab 1994; 79: 1063–9
PubMed
CAS
Article
Google Scholar
Weinstein SP, Paquin T, Pritsker A, et al. Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli. Diabetes 1995; 44: 441–5
PubMed
CAS
Article
Google Scholar
Tojo C, Takao T, Nishioka T, et al. Hypothalamic-pituitary-adrenal axis in WBN/Kob rats with non-insulin dependent diabetes mellitus. Endocr J 1995; 43(2): 233–9
Article
Google Scholar
Lee Z, Chan J, Yeung V, et al. Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. Diabetes Care 1999; 22(9): 1450–7
PubMed
CAS
Article
Google Scholar
Meneilly G, Hill A. Alterations in glucose metabolism in patients with Alzheimer’s disease. J Am Geriatr Soc 1993; 41: 710–4
PubMed
CAS
Google Scholar
Spyer G, Hattersley A, MacDonald I, et al. Hypoglycaemic counter-regulation at normal blood glucose concentrations in patients with well controlled type-2 diabetes. Lancet 2000; 356(9246): 1970–4
PubMed
CAS
Article
Google Scholar
Devaskar SU, Giddings SJ, Rajakumar PA, et al. Insulin gene expression and insulin synthesis in mammalian neuronal cells. J Biol Chem 1994; 269(11): 8445–54
PubMed
CAS
Google Scholar
Rulifson EJ, Kim SK, Nusse R. Ablation of insulin-producing neurons in flies: growth and diabetic phenotypes. Science 2002; 296: 1118–20
PubMed
CAS
Article
Google Scholar
Schechter R, Holtzclaw L, Sadiq F, et al. Insulin synthesis by isolated rabbit neurons. Endocrinology 1988; 23(1): 505–13
Article
Google Scholar
Singh BS, Rajakumar PA, Eves EM, et al. Insulin gene expression in immortalized rat hippocampal and pheochromocytoma-12 cell lines. Regul Pept 1997; 69(1): 7–14
PubMed
CAS
Article
Google Scholar
Hasselbalch SG, Knudsen GM, Videbaek C, et al. No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans. Diabetes 1999 Oct; 48(10): 1915–21
PubMed
CAS
Article
Google Scholar
Squire L, Zola-Morgan S. The medial temporal lobe memory system. Science 1991; 253: 1380–6
PubMed
CAS
Article
Google Scholar
Squire L, Ojemann J, Miezin F, et al. Activation of the hippocampus in normal humans: a functional anatomical study of memory. Proc Natl Acad Sci U S A 1992; 89: 1837–41
PubMed
CAS
Article
Google Scholar
Squire L. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 1992; 99(2): 195–231
PubMed
CAS
Article
Google Scholar
Park CR, Seeley RJ, Craft S, et al. Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Behav 2000; 68: 509–14
PubMed
CAS
Article
Google Scholar
Zhao W, Chen H, Xu H, et al. Brain insulin receptors and spatial memory: correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of the water maze trained rats. J Biol Chem 1999; 274(49): 34893–902
PubMed
CAS
Article
Google Scholar
Marfaing-Jallat P, Portha B, Penicaud L. Altered conditioned taste aversion and glucose utilization in related brain nuclei of diabetic GK rats. Brain Res Bull 1995; 37(6): 639–43
PubMed
CAS
Article
Google Scholar
Greenwood C, Winocur G. Glucose treatment reduces memory deficits in young rats fed high-fat diets. Neurobiol Learn Mem 2001; 75(2): 179–89
PubMed
CAS
Article
Google Scholar
Elias PK, Elias MF, D’Agostino RB, et al. NIDDM and blood pressure as risk factors for poor cognitive performance: the Framingham Study. Diabetes Care 1997; 20(9): 1388–95
PubMed
CAS
Article
Google Scholar
Helkala E-L, Niskanen L, Viinamaki H, et al. Short-term and long-term memory in elderly patients with NIDDM. Diabetes Care 1995; 18(5): 681–5
PubMed
CAS
Article
Google Scholar
Perlmuter LC, Hakami MK, Hodgson-Harrington C, et al. Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am J Med 1984; 77: 1043–8
PubMed
CAS
Article
Google Scholar
Strachan M, Deary I, Ewing F, et al. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 1997 Mar; 20(3): 438–45
PubMed
CAS
Article
Google Scholar
Vanhanen M, Kuusisto J, Koivisto K, et al. Type-2 diabetes and cognitive function in a non-demented population. Acta Neurol Scand 1999; 100: 97–101
PubMed
CAS
Article
Google Scholar
Vanhanen M, Koivisto K, Kuusisto J, et al. Cognitive function in an elderly population with persistent impaired glucose tolerance. Diabetes Care 1998; 21(3): 398–402
PubMed
CAS
Article
Google Scholar
Ryan C, Geckle M. Why is learning and memory dysfunction in type 2 diabetes limited to older adults? Diabetes Metab Res Rev 2000; 16: 308–15
PubMed
CAS
Article
Google Scholar
Gregg E, Yaffe K, Cauley J, et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Arch Intern Med 2000; 160: 174–80
PubMed
CAS
Article
Google Scholar
Kalmijn S, Feskens E, Launer L, et al. Glucose intolerance, hyperinsulinemia and cognitive function in a general population of elderly men. Diabetologia 1995; 38: 1096–102
PubMed
CAS
Article
Google Scholar
Meneilly GS, Cheung E, Tessier D, et al. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J Gerontol 1993; 48(4): M117–M21
PubMed
CAS
Article
Google Scholar
Reaven G, Thompson L, Nahum D, et al. Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 1990; 13(1): 16–21
PubMed
CAS
Article
Google Scholar
Skeberdis V, Lan J, Zheng X, et al. Insulin promotes rapid delivery of N-methyl-D-aspartate receptors to the cell surface by exocytosis. Proc Natl Acad Sci U S A 2001; 98(6): 3561–6
PubMed
CAS
Article
Google Scholar
Gould E, Tanapat P. Stress and hippocampal neurogenesis. Biol Psychiatry 1999; 46(11): 1472–9
PubMed
CAS
Article
Google Scholar
Joels M, de Kloet E. Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus. Science 1989; 245(4925): 1502–5
PubMed
CAS
Article
Google Scholar
Pavlides C, McEwen BS. Effects of mineralocorticoid and glucocorticoid receptors on long-term potentiation in the CA3 hippocampal field. Brain Res 1999; 851: 204–14
PubMed
CAS
Article
Google Scholar
Xu L, Holscher C, Anwyl R, et al. Glucocorticoid receptor and protein/RNA synthesis-dependent mechanisms underlie the control of synaptic by stress. Proc Natl Acad Sci U S A 1998; 95: 3204–8
PubMed
CAS
Article
Google Scholar
de Quervain DJ, Roozendaal B, Nitsch RM, et al. Acute cortisone administration impairs retrieval of long-term declarative memory in humans. Nat Neurosci 2000; 3(4): 313–4
PubMed
Article
Google Scholar
Forget H, Lacroix A, Somma M, et al. Cognitive decline in patients with Cushing’s syndrome. J Int Neuropsychol Soc 2000; 6: 20–9
PubMed
CAS
Google Scholar
Greendale G, Kritz-Silverstein D, Seeman T, et al. Higher basal cortisol predicts verbal memory loss in postmenopausal women: Rancho Bernardo study. J Am Geriatr Soc 2000; 48(12): 1655–8
PubMed
CAS
Google Scholar
Lupien S, Lecours AR, Lussier I, et al. Basal cortisol levels and cognitive deficits in human aging. J Neurosci 1994; 14 (5 Pt 1): 2893–903
PubMed
CAS
Google Scholar
Miller T, Taylor J, Rogerson S, et al. Cognitive and noncognitive symptoms in dementia patients: relationship to cortisol and dehydroepiandrosterone. Int Psychogeriatr 1998; 10(1): 85–96
PubMed
CAS
Article
Google Scholar
Newcomer J, Craft S, Hershey T, et al. Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci 1994; 14: 2047–53
PubMed
CAS
Google Scholar
Newcomer JW, Selke G, Melson AK, et al. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry 1999; 56: 527–33
PubMed
CAS
Article
Google Scholar
Young A, Sahakian B, Robbins T, et al. The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacology (Berl) 1999; 145(3): 260–6
CAS
Article
Google Scholar
Brown ES, Rush J, McEwen BS. Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology 1999; 21(4): 74–84
Article
Google Scholar
Brunetti A, Fulham JJ, Aloj L, et al. Decreased brain glucose utilization in patients with Cushing’s disease. J Nucl Med 1998; 39(5): 786–90
PubMed
CAS
Google Scholar
Sapolsky R, Uno H, Rebert C, et al. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 1990; 10(9): 2897–902
PubMed
CAS
Google Scholar
Sapolsky R. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000; 57(10): 925–35
PubMed
CAS
Article
Google Scholar
Starkman M, Giordani B, Gebarski S, et al. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing’s disease. Biol Psychiatry 1999; 46(12): 1595–602
PubMed
CAS
Article
Google Scholar
LeMay DR, Gehua L, Zelenock GB, et al. Insulin administration protects neurologic function in cerebral ischemia in rats. Stroke 1988 Nov; 19(11): 1411–9
PubMed
CAS
Article
Google Scholar
Li PA, Shuaib A, Miyashita H, et al. Hyperglycemia enhances extracellular glutamate accumulation in rats subjected to forebrain ischemia. Stroke 2000; 31(1): 183–92
PubMed
CAS
Article
Google Scholar
Atlante A, Calissano P, Bobba A, et al. Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett 2001; 497(1): 1–5
PubMed
CAS
Article
Google Scholar
Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neuro-degenerative disorders. Science 1993; 262(5134): 689–95
PubMed
CAS
Article
Google Scholar
Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998; 88(9): 1337–42
PubMed
CAS
Article
Google Scholar
Kawas C, Gray S, Brookmeyer R, et al. Age-specific incidence rates of Alzheimer’s disease: the Baltimore Longitudinal Study of Aging. Neurology 2000; 13(411): 2072–7
Article
Google Scholar
Polvikoski T, Sulkava R, Myllykangas L, et al. Prevalence of Alzheimer’s disease in very elderly people: a prospective neuropathological study. Neurology 2001; 56: 1690–6
PubMed
CAS
Article
Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
Google Scholar
Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303–8
PubMed
CAS
Article
Google Scholar
Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58(12): 1985–92
PubMed
CAS
Article
Google Scholar
Razay G, Wilcock GK. Hyperinsulinemia and Alzheimer’s disease. Age Ageing 1994; 23: 396–9
PubMed
CAS
Article
Google Scholar
Craft S, Asthana S, Schellenberg GD, et al. Insulin metabolism in Alzheimer’s disease differs according to apolipoprotein E genotype and gender. Neuroendocrinology 1999; 70: 146–52
PubMed
CAS
Article
Google Scholar
Craft S, Peskind E, Schwartz MW, et al. Cerebrospinal fluid and plasma insulin levels in Alzheimer’s disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 1998; 50: 164–8
PubMed
CAS
Article
Google Scholar
Leibson C, Rocca W, Hanson V, et al. The risk of dementia among persons with diabetes mellitus: a population-based cohort study. Ann N Y Acad Sci 1997; 826: 422–7
PubMed
CAS
Article
Google Scholar
Ott A, Stolk RP, van Harskamp F, et al. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 1999; 10: 1937–42
Article
Google Scholar
Corder E, Saunders A, Strittmatter W, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 1993; 261(5123): 921–3
PubMed
CAS
Article
Google Scholar
Kuusisto J, Koivisto K, Mykkanen L, et al. Association between features of the insulin resistance syndrome and Alzheimer’s disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ 1997; 315: 1045–9
PubMed
CAS
Article
Google Scholar
Foster NL, Chase TN, Fedio P, et al. Alzheimer’s disease: focal cortical changes shown by positron emission tomography. Neurology 1983; 33(8): 961–5
PubMed
CAS
Article
Google Scholar
Rodriguez G, Vitali P, Calvini P, et al. Hippocampal perfusion in mild Alzheimer’s disease. Psychiatry Res 2000; 100(2): 65–74
PubMed
CAS
Article
Google Scholar
De Santi S, de Leon MJ, Rusinek H, et al. Hippocampal formation glucose metabolism and volume losses in MCI and Alzheimer’s disease. Neurobiol Aging 2001; 22(4): 529–39
PubMed
Article
Google Scholar
Craft S, Asthana S, Newcomer J, et al. Insulin-induced enhancement of memory in Alzheimer’s disease is independent of glucose. Soc Neurosci Abstr 1996; 22(2): 1177
Google Scholar
Craft S, Zallen G, Baker LD. Glucose and memory in mild senile dementia of the Alzheimer’s type. J Clin Exp Neuropsychol 1992; 14: 253–67
PubMed
CAS
Article
Google Scholar
Craft S, Murphy C, Wemstrom J. Glucose effects on complex memory and non-memory tasks: the influence of age, sex, and glucoregulatory response. Psychobiology 1994; 22: 95–105
CAS
Google Scholar
Newcomer JW, Craft S, Fucetola R, et al. Glucose-induced increase in memory performance in patients with schizophrenia. Schizophr Bull 1999; 25(2): 321–35
PubMed
CAS
Article
Google Scholar
Craft S, Newcomer J, Kanne S, et al. Memory improvement following induced hyperinsulinemia in Alzheimer’s disease. Neurobiol Aging 1996; 17(1): 123–30
PubMed
CAS
Article
Google Scholar
Craft S, Asthana S, Schellenberg G, et al. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer’s disease differ according to apolipoprotein-E genotype. Ann N Y Acad Sci 2000; 903: 222–8
PubMed
CAS
Article
Google Scholar
Craft S, Asthana S, Cook DG, et al. Insulin dose response effects on memory and amyloid precursor protein in Alzheimer’s disease: interactions with apolipoprotein E genotype. Psychoneuroendocrinology. In press
Sinha S, Lieberburg I. Cellular mechanisms of beta-amyloid production and secretion. Proc Natl Acad Sci U S A 1999; 96(20): 11049–53
PubMed
CAS
Article
Google Scholar
Kienlen-Campard P, Miolet S, Tasiaux B, et al. Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis. J Biol Chem 2002; 277(18): 15666–70
PubMed
CAS
Article
Google Scholar
Naslund J, Haroutunian V, Mohs R, et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 2000; 283(12): 1571–7
PubMed
CAS
Article
Google Scholar
Parvathy S, Davies P, Haroutunian V, et al. Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline. Arch Neurol 2001; 58(12): 2025–32
PubMed
CAS
Article
Google Scholar
Arriagada PV, Growdon JH, Hedley-Whyte ET, et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 1992; 42: 631–9
PubMed
CAS
Article
Google Scholar
Jellinger KA. The neuropathological diagnosis of Alzheimer disease. J Neural Transm Suppl 1998; 53: 97–118
PubMed
CAS
Article
Google Scholar
Tilley L, Morgan K, Kalsheker N. Genetic risk factors in Alzheimer’s disease. Mol Pathol 1998; 51: 293–304
PubMed
CAS
Article
Google Scholar
Gyure KA, Durham R, Stewart WF, et al. Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. Arch Pathol Lab Med 2001; 125(4): 489–92
PubMed
CAS
Google Scholar
Xia W, Ostaszewski BL, Kimberly WT, et al. Alzheimer’s disease mutations in presenilin-1 or amyloid precursor protein decrease the efficacy of a gamma-secretase inhibitor: evidence for direct involvement of PS 1 in the gamma-secretase cleavage complex. Neurobiol Dis 2000; 7 (6 Pt B): 673–81
PubMed
CAS
Article
Google Scholar
Authier F, Posner BI, Bergeron JJM. Insulin-degrading enzyme. Clin Invest Med 1996; 19(3): 149–60
PubMed
CAS
Google Scholar
Kurochkin IV, Goto S. Alzheimer’s B-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 1994; 345: 33–7
PubMed
CAS
Article
Google Scholar
McDermott JR, Gibson AM. Degradation of Alzheimer’s beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme. Neurochem Res 1997; 22(1): 49–56
PubMed
CAS
Article
Google Scholar
Qiu W, Walsh D, Ye Z, et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 1998; 273(49): 32730–8
PubMed
CAS
Article
Google Scholar
Vekrellis K, Ye Z, Qiu WQ, et al. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 2000; 20(5): 1657–65
PubMed
CAS
Google Scholar
Sudoh S, Frosch MP, Wolf BA. Differential effects of proteases involved in intracellular degradation of amyloid β-protein between detergent-soluble and -insoluble pools in CHO-695 cells. Biochemistry 2002; 41(4): 1091–9
PubMed
CAS
Article
Google Scholar
Edbauer D, Willem M, Lammich S, et al. Insulin-degrading enzyme rapidly removes the β-amyloid precursor protein intracellular domain (AICD). J Biol Chem 2002; 277(16): 13389–93
PubMed
CAS
Article
Google Scholar
Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer’s disease. Neurobiol Aging 2000; 21(3): 383–421
PubMed
CAS
Article
Google Scholar
Rogers J, Shen Y. A perspective on inflammation in Alzheimer’s disease. Ann N Y Acad Sci 2000; 924: 132–5
PubMed
CAS
Article
Google Scholar
Lue LF, Walker DG, Rogers J. Modeling microglial activation in Alzheimer’s disease with human postmortem microglial cultures. Neurobiol Aging 2001; 22(6): 945–56
PubMed
CAS
Article
Google Scholar
Lim GP, Yang F, Chu T, et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer’s disease. J Neurosci 2000; 20(15): 5709–14
PubMed
CAS
Google Scholar
Anthony JC, Breitner JC, Zandi PP, et al. Reduced prevalence of Alzheimer’s disease in users of NSAIDs and H2 receptor antagonists: the Cache County study. Neurology 2000; 54(11): 2066–71
PubMed
CAS
Article
Google Scholar
Broe GA, Grayson DA, Creasey HM, et al. Anti-inflammatory drugs protect against Alzheimer disease at low doses. Arch Neurol 2000; 57(11): 1586–91
PubMed
CAS
Article
Google Scholar
Rosier N, Wichart I, Jellinger KA. Intra vitam lumbar and post mortem ventricular cerebrospinal fluid immunoreactive interleukin-6 in Alzheimer’s disease patients. Acta Neurol Scand 2001; 103(2): 126–30
Article
Google Scholar
Hull M, Strauss S, Berger M, et al. The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer’s disease. Behav Brain Res 1996; 78(1): 37–41
PubMed
CAS
Article
Google Scholar
Hak AE, Pols HA, Stehouwer CD, et al. Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab 2001; 86(9): 4398–405
PubMed
CAS
Article
Google Scholar
Pickup JC, Mattock MB, Chusney GD, et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40(11): 1286–92
PubMed
CAS
Article
Google Scholar
Fernandez-Real JM, Broch M, Vendrell J, et al. Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes 2000; 49: 517–20
PubMed
CAS
Article
Google Scholar
Combs CK, Johnson DE, Karlo JC, et al. Inflammatory mechanisms in Alzheimer’s disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPAR-γ agonists. J Neurosci 2000; 20(2): 558–67
PubMed
CAS
Google Scholar
Hoyer S. Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update. Exp Gerontol 2000; 35: 1363–72
PubMed
CAS
Article
Google Scholar
Frölich L, Blum-Degen D, Bernstein HG, et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease. J Neural Transm 1998; 105: 423–38
PubMed
Article
Google Scholar
Hoyer S, Lee SK, Loffler T, et al. Inhibition of the neuronal insulin receptor: an in vivo model for sporadic Alzheimer disease? Ann N Y Acad Sci 2000; 920: 256–8
PubMed
CAS
Article
Google Scholar
Kagansky N, Levy S, Knobler H. The role of hyperglycemia in acute stroke. Arch Neurol 2001 Aug; 58(8): 1209–12
PubMed
CAS
Article
Google Scholar
Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care 1998 Dec; 21 Suppl. 3: C11–4
Google Scholar
Malinowski J, Bolesta S. Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review. Clin Ther 2000; 22(10): 1151–68
PubMed
CAS
Article
Google Scholar
da Silva B, Molitch M. Pharmacologic management of type 2 diabetes in the elderly: overview of treatment options. Formulary 2000; 35: 580–94
Google Scholar
Dunn C, Faulds D. Nateglinide. Drugs 2000; 60(3): 607–15
PubMed
CAS
Article
Google Scholar
Evans AJ, Krentz AJ. Recent developments and emerging therapies for type 2 diabetes mellitus. Drugs R D 1999; 2: 75–94
PubMed
CAS
Article
Google Scholar
Hevener AL, Reichart D, Olefsky J. Exercise and thiazolid-inedione therapy normalize insulin action in the obese Zucker fatty rat. Diabetes 2000; 49(12): 2154–9
PubMed
CAS
Article
Google Scholar
Kennedy JW, Hirshman MF, Gervino EV, et al. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes 1999; 48(5): 1192–7
PubMed
CAS
Article
Google Scholar
Young PW, Cawthorne MA, Coyle PJ, et al. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes: association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling. Diabetes 1995; 44(9): 1087–92
PubMed
CAS
Article
Google Scholar
Gibbs EM, Stock JL, McCoid SC, et al. Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J Clin Invest 1995; 95(4): 1512–8
PubMed
CAS
Article
Google Scholar
Kuusisto J, Koivisto K, Mykkanen L, et al. Essential hypertension and cognitive function: the role of hyperinsulinemia. Hypertension 1993; 22: 771–9
PubMed
CAS
Article
Google Scholar
Stolk R, Breteler M, Alewijn O, et al. Insulin and cognitive function in an elderly population. Diabetes Care 1997; 20(5): 792–5
PubMed
CAS
Article
Google Scholar
Richardson JTE. Cognitive function in diabetes mellitus. Neurosci Behav Rev 1989; 14: 385–8
Article
Google Scholar
Reaven G, Thompson L. Reduced cognitive function in older patients with non-insulin dependent diabetes: relationship and severity of hyperglycemia. Diabetes Care 1990; 13(1): 16–21
PubMed
CAS
Article
Google Scholar
Gradman T, Laws A, Thompson L, et al. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J Am Geriatr Soc 1993; 41: 1305–12
PubMed
CAS
Google Scholar
De Angelis Lobo d’Avila K, Gadonski G, Fang J, et al. Exercise reverses peripheral insulin resistance in trained L-NAME-hypertensive rats. Hypertension 1999; 34: 768–22
PubMed
Article
Google Scholar
Mayer-Davis E, D’Agostino R, Karter A, et al. Intensity and amount of physical activity in relation to insulin sensitivity: the insulin resistance atherosclerosis study. JAMA 1998; 279(9): 669–74
PubMed
CAS
Article
Google Scholar
Carro E, Trejo JL, Busiguina S, et al. Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J Neurosci 2001; 21(15): 5678–84
PubMed
CAS
Google Scholar
Laurin D, Verreault R, Lindsay J, et al. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 2001; 58(3): 498–504
PubMed
CAS
Article
Google Scholar
Pignatti F, Rozzini R, Trabucchi M. Physical activity and cognitive decline in elderly persons. Arch Intern Med 2002; 11(62): 361–2
Article
Google Scholar
Yaffe K, Barnes D, Nevitt M, et al. A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch Intern Med 2001; 161(14): 1703–8
PubMed
CAS
Article
Google Scholar
Kramer AF, Hahn S, Cohen NJ, et al. Ageing, fitness and neuro-cognitive function. Nature 1999; 400(6743): 418–9
PubMed
CAS
Article
Google Scholar
Watson GS, Fujimoto W, Petrova A, et al. Exercise and diet are associated with improved memory in Japanese-Americans with impaired glucose tolerance (IGT) [abstract #72]. Society of Neuroscience’s 31st Annual Meeting; 2001 Nov 10–15; San Diego. Soc Neurosci Abstr 2001; 27 (Program no. 72.13)
Peskind ER, Wilkinson CW, Petrie EC, et al. Increased CSF cortisol in Alzheimer’s disease is a function of APOE genotype. Neurology 2001; 56(8): 1094–8
PubMed
CAS
Article
Google Scholar
Jack CR, Dickson DW, Parisi JE, et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002; 58(5): 750–7
PubMed
Article
Google Scholar
Delerive P, Fruchart J-C, Staels B. Paroxisome proliferator-activated receptors in inflammation control. J Endocrinol 2001; 169: 453–9
PubMed
CAS
Article
Google Scholar
Paik JH, Ju JH, Lee JY, et al. Two opposing effects of non-steroidal anti-inflammatory drugs on the expression of inducible cyclooxygenase: mediation through different signaling pathways. J Biol Chem 2000; 275(36): 28173–9
PubMed
CAS
Google Scholar
Longstreth Jr WT, Dulberg C, Manolio TA, et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2002 Oct; 33(10): 2376–82
PubMed
Article
Google Scholar